Article Details

Roche gets WHO prequalification for Tocilizumab to treat severe COVID-19 - Medical Dialogues

Retrieved on: 2022-02-12 07:37:13

Tags for this article:

Click the tags to see associated articles and topics

Roche gets WHO prequalification for Tocilizumab to treat severe COVID-19 - Medical Dialogues. View article details on hiswai:

Excerpt

Basel: Roche has announced that Actemra/RoActemra (tocilizumab) intravenous (IV) has been granted World Health Organization (WHO) prequalification ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up